SOAT1 and hepatocellular carcinoma: A proteomics analysis found that high expression of SOAT1 was a signature specific to the S‐III subtype, which alters the distribution of cellular cholesterol, and suppresses the proliferation and migration of hepatocellular carcinoma effectively [10].